Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Gains from Sales and Divestitures (2021 - 2024)

Historic Gains from Sales and Divestitures for Definitive Healthcare (DH) over the last 4 years, with Q4 2024 value amounting to $2.7 million.

  • Definitive Healthcare's Gains from Sales and Divestitures rose 10484.86% to $2.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.7 million, marking a year-over-year increase of 10484.86%. This contributed to the annual value of $2.7 million for FY2024, which is 10484.86% up from last year.
  • According to the latest figures from Q4 2024, Definitive Healthcare's Gains from Sales and Divestitures is $2.7 million, which was up 10484.86% from $1.3 million recorded in Q4 2023.
  • Definitive Healthcare's 5-year Gains from Sales and Divestitures high stood at $2.7 million for Q4 2024, and its period low was $74049.0 during Q3 2021.
  • Moreover, its 4-year median value for Gains from Sales and Divestitures was $906377.0 (2022), whereas its average is $893327.4.
  • Per our database at Business Quant, Definitive Healthcare's Gains from Sales and Divestitures soared by 112402.33% in 2022 and then skyrocketed by 2267.11% in 2023.
  • Over the past 4 years, Definitive Healthcare's Gains from Sales and Divestitures (Quarter) stood at $74049.0 in 2021, then skyrocketed by 1332.0% to $1.1 million in 2022, then rose by 22.67% to $1.3 million in 2023, then skyrocketed by 104.85% to $2.7 million in 2024.
  • Its Gains from Sales and Divestitures was $2.7 million in Q4 2024, compared to $1.3 million in Q4 2023 and $1.1 million in Q4 2022.